Want to see PCRX full AI Analyst Report?
Pacira Pharmaceuticals (PCRX) Income Statement
Pacira Pharmaceuticals Income Statement
Last quarter (Q2 2026), Pacira Pharmaceuticals's total revenue was $192.40M, an increase of 6.24% from the same quarter last year. In Q2, Pacira Pharmaceuticals's net income was $4.65M. See Pacira Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 726.41M | $ 700.97M | $ 674.98M | $ 666.82M | $ 541.53M | |
| $ 576.66M | $ 530.54M | $ 490.31M | $ 467.53M | $ 401.28M | |
| $ 543.36M | $ 603.91M | $ 402.63M | $ 407.50M | $ 311.35M | |
| Depreciation and Amortization | $ 91.02M | $ 78.78M | $ 75.57M | $ 91.50M | $ 28.55M |
| $ 122.50M | $ 29.12M | $ 154.59M | $ 140.38M | $ 113.95M | |
| $ 33.30M | $ -73.37M | $ 87.67M | $ 60.02M | $ 89.92M | |
| $ -16.43M | $ 10.27M | $ -25.97M | $ -46.72M | $ -33.52M | |
| $ 16.87M | $ -63.11M | $ 61.70M | $ 13.30M | $ 56.40M | |
| $ 7.03M | $ -99.56M | $ 41.95M | $ 15.91M | $ 41.98M | |
| Per Share Metrics | |||||
| Basic EPS | $ 0.16 | $ -2.15 | $ 0.91 | $ 0.35 | $ 0.95 |
| Diluted EPS | $ 0.16 | $ -2.15 | $ 0.89 | $ 0.34 | $ 0.92 |
| Weighted Average Shares Outstanding | 44.57M | 46.24M | 46.22M | 45.52M | 44.26M |
| Weighted Average Shares Outstanding (Diluted) | 45.04M | 46.24M | 51.98M | 46.54M | 45.63M |
Currency in USD